About: BPIQ-II   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, is a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediates inhibition of endogenous biological pathways for inhibition of axonal regeneration that are mediated through membraneous myelin and chondroitin sulfate proteoglycans. It was discovered in 1996 by Rewcastle et al. at the University of Auckland School of Medicine in New Zealand and Parke-Davis Pharmaceutical Research in Michigan.

AttributesValues
rdfs:label
  • BPIQ-II
rdfs:comment
  • BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, is a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediates inhibition of endogenous biological pathways for inhibition of axonal regeneration that are mediated through membraneous myelin and chondroitin sulfate proteoglycans. It was discovered in 1996 by Rewcastle et al. at the University of Auckland School of Medicine in New Zealand and Parke-Davis Pharmaceutical Research in Michigan.
  • BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, was a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediated inhibition of endogenous biological pathways for inhibition of axonal regeneration that were mediated through membranous myelin and chondroitin sulfate proteoglycans.
dcterms:subject
dbkwik:halo-fanon/...iPageUsesTemplate
dbkwik:halofanon/p...iPageUsesTemplate
dbkwik:swfanon/pro...iPageUsesTemplate
abstract
  • BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, is a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediates inhibition of endogenous biological pathways for inhibition of axonal regeneration that are mediated through membraneous myelin and chondroitin sulfate proteoglycans. It was discovered in 1996 by Rewcastle et al. at the University of Auckland School of Medicine in New Zealand and Parke-Davis Pharmaceutical Research in Michigan.
  • BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, was a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediated inhibition of endogenous biological pathways for inhibition of axonal regeneration that were mediated through membranous myelin and chondroitin sulfate proteoglycans.
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software